Youhui Lin

Dr. Youhui Lin

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2014 in Accounts of Chemical Research
Verified
Journal Article
Closed access
YLYouhui Lin
Youhui Lin
JRJinsong Ren
Jinsong Ren
XQXiaogang Qu
Xiaogang Qu

28 November 2011 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
LZLi Zhou
Li Zhou
YLYouhui Lin
Youhui Lin
ZHZhenzhen Huang
Zhenzhen Huang
JRJinsong Ren
Jinsong Ren
XQXiaogang Qu
Xiaogang Qu
In this work, unmodified carbon nanodots are demonstrated as novel and environmentally-friendly fluorescence probes for the sensing of Hg2+ and biothiols with high sensitivity and selectivity.


1 April 2014 in Advanced Materials
Verified
Journal Article
Closed access
PDF file
YLYouhui Lin
Youhui Lin
JRJinsong Ren
Jinsong Ren
XQXiaogang Qu
Xiaogang Qu

1 April 2013 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
YTYu Tao
Yu Tao
YLYouhui Lin
Youhui Lin
JRJinsong Ren
Jinsong Ren
XQXiaogang Qu
Xiaogang Qu

5 April 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
YPYongchun Pan
Yongchun Pan
JYJingjing Yang
Jingjing Yang
XLXiaowei Luan
Xiaowei Luan
XLXinli Liu
Xinli Liu
XLXueqing Li
Xueqing Li
YSYujun Song
Yujun Song
As an RNA-guided nuclease, CRISPR-Cas9 offers facile and promising solutions to mediate genome modification with respect to versatility and high precision. However, spatiotemporal manipulation of CRISPR-Cas9 delivery remains a daunting challenge for robust effectuation of gene editing both in vitro and in vivo. Here, we designed a near-infrared (NIR) light–responsive nanocarrier of CRISPR-Cas9 for cancer therapeutics based on upconversion nanoparticles (UCNPs). The UCNPs served as “nanotransducers” that can convert NIR light (980 nm) into local ultraviolet light for the cleavage of photosensitive molecules, thereby resulting in on-demand release of CRISPR-Cas9. In addition, by preparing a single guide RNA targeting a tumor gene (polo-like kinase-1), our strategies have successfully inhibited the proliferation of tumor cell via NIR light–activated gene editing both in vitro and in vivo. Overall, this exogenously controlled method presents enormous potential for targeted gene editing in deep tissues and treatment of a myriad of diseases.